CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,729,202 | +1258.6% | 3,499,833 | +1107.9% | 0.05% | +1125.0% |
| Q2 2023 | $1,231,391 | -20.0% | 289,739 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $1,538,514 | -15.4% | 289,739 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $1,819,561 | +15.7% | 289,739 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $1,573,000 | -40.9% | 289,739 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $2,660,000 | -39.2% | 289,739 | 0.0% | 0.01% | -35.3% |
| Q4 2021 | $4,372,000 | -36.8% | 289,739 | 0.0% | 0.02% | -43.3% |
| Q3 2021 | $6,916,000 | – | 289,739 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
| 72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
| Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
| PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
| Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
| CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
| Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
| Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
| Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
| Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |